Brain Metastases News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Novel Agents Show Signs of Efficacy Against Brain Metastases - OncLive



OncLive
 
Novel Agents Show Signs of Efficacy Against Brain Metastases 
OncLive
Although many new therapies have been introduced in a range of cancer types, brain metastases remain a serious neurological complication in patients with advanced malignancies. In the past, patients with a single brain metastasis were treated with ...

 


Partial Response Reported With Abemaciclib for Breast Cancer Metastases to Brain - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Partial Response Reported With Abemaciclib for Breast Cancer Metastases to Brain 
Oncology Nurse Advisor
This study included 23 patients with HR+ metastatic breast cancer and at least one measurable brain lesion. Currently no systemic agents are approved for the treatment of hormone receptor-positive (HR+) breast cancer brain metastases. In a recent phase ...
Prolonged Progression-Free Survival Reinforces Tucatinib's Potential for Patients with Advanced HER2+ Metastatic ... GlobeNewswire (press release)

all 191 news articles » 


Study analyzes mutations in cerebrospinal fluid in lung cancer with brain metastases - EurekAlert (press release)



Study analyzes mutations in cerebrospinal fluid in lung cancer with brain metastases 
EurekAlert (press release)
LUGANO, 17 November 2017 - Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study presented at the ESMO Asia 2017 Congress. (1) Tumour tissue from brain metastasis is ...

and more » 


Over 1000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific Software - Business Wire (press release)



Business Wire (press release)
 
Over 1000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific Software 
Business Wire (press release)
MUNICH--(BUSINESS WIRE)--Accelerated adoption of the Elements Multiple Brain Mets SRS software resulted in over 1,000 patients treated today, with the number of institutions adopting the technology and patients per site doubling in just the past eight ...

and more » 


Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis 
Oncology Nurse Advisor
Patients with HER2-positive (HER2+) breast cancer are more likely to develop brain metastases based on when presence of metastases is diagnosed, postmenopausal status, treatment approach, and patient age, according to a study to be presented at the ...

 


Sites of metastasis and overall survival in esophageal cancer: a population-based study - Dove Medical Press



Sites of metastasis and overall survival in esophageal cancer: a population-based study 
Dove Medical Press
Results: We included 3218 patients in this study; the most common site of DM was the liver, followed by distant lymph nodes, lung, bone and brain. Median OS for patients with liver, distant lymph node, lung, bone, and brain metastases was 5, 10, 6, 4 ...

 


Metastatic Melanoma - News-Medical.net



News-Medical.net
 
Metastatic Melanoma 
News-Medical.net
Melanoma is a type of skin cancer. When melanoma spreads to other parts of the body, it's called metastatic melanoma, or stage IV melanoma. Some common sites for metastatic melanoma are the liver, lungs, bones, and brain. Melanoma is a cancer of ...

 


Update Sustains Osimertinib Activity Against CNS Mets in NSCLC - OncLive



OncLive
 
Update Sustains Osimertinib Activity Against CNS Mets in NSCLC 
OncLive
?CNS metastases, including brain metastases, are a common and very disabling complication of advanced EGFR mutation?positive NSCLC. They are notoriously difficult to treat, as existing oral therapies are often unable to effectively cross the blood ...
BRIEF?Tagrisso data show benefits in fighting lung cancer complication The Pharma Letter
Osimertinib improves progression-free survival in Asian EGFR-mutated lung cancer patients EurekAlert (press release)
New England Journal of Medicine publishes results of phase III FLAURA trial in the 1st-line treatment of EGFR ... Hindu Business Line

all 9 news articles » 


Pfizer (PFE) Announces Talazoparib Significantly Extends PFS in Phase 3 EMBRACA Trial of Patients with Metastatic ... - StreetInsider.com



TIME
 
Pfizer (PFE) Announces Talazoparib Significantly Extends PFS in Phase 3 EMBRACA Trial of Patients with Metastatic ... 
StreetInsider.com
By enrolling only patients with germline BRCA-positive metastatic breast cancer, treatment with talazoparib reduced the risk of disease worsening by nearly half, compared with current standard of care chemotherapy. This includes heavily pretreated ...
Contemporary Hormonal Contraception and the Risk of Breast Cancer ? NEJM - The New England Journal of Medicine The New England Journal of Medicine

all 143 news articles » 


Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic ... - Business Wire (press release)



Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic ... 
Business Wire (press release)
?Results from the EMBRACA study are very encouraging and a great example of precision drug development. By enrolling only patients with germline BRCA-positive metastatic breast cancer, treatment with talazoparib reduced the risk of disease worsening by ...

and more »